Dry Mouth on a GLP-1: What the Labels Report

A dry mouth is one of those symptoms people mention in passing, half assuming it is too small to count. On GLP-1 medications it occupies an interesting position: real enough to appear in official adverse reaction tables, small enough that the numbers around it are tiny, and uneven enough across the class that the labels disagree about whether to mention it at all. All three of those facts belong together, and together they are the subject of this page.

Two labels list it, three do not

Of the five major GLP-1 labels, two carry dry mouth in their adverse reaction tables and three carry no mention of it anywhere. Saxenda lists dry mouth among reactions occurring in at least 2 percent of treated adults and more frequently than placebo: 2.3 percent on Saxenda versus 1 percent on placebo, from a table built on 1,941 placebo patients and 3,384 Saxenda patients. Zepbound reports dry mouth or dry throat in 1 percent of treated patients versus 0.1 percent of placebo patients, pooled across its two main weight trials. The Wegovy, Ozempic and Mounjaro labels contain no mention of dry mouth at all.

There is mouth-adjacent content elsewhere in the labels, for context only. The Ozempic label lists dysgeusia, an altered sense of taste, among reactions reported at a frequency above 0.4 percent, and the Zepbound label reports dysgeusia in 0.4 percent of treated patients versus none on placebo. Taste and dryness travel through the same neighborhood, but they are separate entries, and neither label connects them to the other.

Reading the numbers honestly

The numbers are small, and the honest reading starts with the column beside them: the placebo column is not zero. One person in a hundred on Zepbound reported dry mouth or dry throat, against one in a thousand on placebo. Roughly one in forty-three on Saxenda, against one in a hundred on placebo. Both differences are real in the sense that the trials captured them more often on the drug than off it, and both are small in the sense that almost nobody in either arm reported anything at all. The useful reading is neither rare therefore unreal nor common enough to expect; it is that this is what the trials captured, which is the only thing an adverse reaction table has ever been.

Then there is the strangest fact on the page. Mounjaro and Zepbound are the same molecule, tirzepatide, and only the Zepbound label lists dry mouth. The explanation is mundane and worth internalizing: adverse reaction tables come from each product's own trial programme, with its own population, its own dosing context and its own reporting conventions. A reaction missing from one label is not evidence that it does not happen on that product. That principle generalizes far beyond dry mouths, and How to Read Your GLP-1's Prescribing Information is the page that teaches it properly.

GLP 1 Tracker AppWater logged in a tap and side effects dated with severity, all free, on your phone. A pattern you can show instead of one you try to remember. Get the app

Dry mouth and dehydration, stated precisely

The dehydration question deserves precision, because the labels are more precise about it than a game of telephone would suggest. What the labels actually tie dehydration to is the gastrointestinal reactions, nausea, vomiting and diarrhea, and they warn that dehydration has led to acute kidney injury. That is the documented chain: fluid loss through the gut, then dehydration, then a serious renal consequence. No label presents dry mouth as a sign of dehydration. So the accurate statement runs the other way around from the folk version: a dry mouth may accompany not drinking enough, and the labels' documented worry is the dehydration itself, not the dry mouth. What any one person's symptom means is a clinical question; drinking steadily is the habit everything points at anyway, and Why Hydration Matters More on a GLP-1 covers under-drinking on these medicines while Diarrhea on a GLP-1: Patterns Worth Tracking covers the fluid-loss end.

Why a dentist is the right audience

Saliva is not decoration. It is part of how a mouth protects itself, continuously, and a mouth that is persistently dry is a recognized thing for dentists to know about, not a curiosity to apologize for mentioning. No GLP-1 label discusses dental consequences of dry mouth, which means no risk figure exists to quote and none should be invented here. What can be said is simple: if a dry mouth persists, the person to raise it with is a dentist, at an ordinary appointment, in the same matter-of-fact register as any other symptom. This site takes the same position on products for dry mouth that it takes on products for loose skin at Loose Skin and Rapid Weight Loss: recommend nothing, let the professional who can see the situation do the recommending.

What to do with it practically

The practical response is unglamorous. Water logging is free in the app, and sipping through the day rather than drinking in heroic intervals is the obvious habit. For the symptom itself, the side effect diary takes an entry with a date and a severity rating, which is exactly what a pattern needs: a dry mouth that shows up in the diary on a Tuesday, persists through the following week and is still there at the next appointment is a documented fact, while one described from memory three weeks later is an impression. A clinician or dentist can work with the first and not the second. Everything stays on the phone, with no account and nothing collected.